Marucci Laura, Farneti Alessia, Di Ridolfi Paolo, Pinnaro Paola, Pellini Raul, Giannarelli Diana, Vici Patrizia, Conte Mario, Landoni Valeria, Sanguineti Giuseppe
Department of Radiation Oncology, Regina Elena National Cancer Institute, Rome, Italy.
Department of Head and Neck Surgery, Regina Elena National Cancer Institute, Rome, Italy.
Head Neck. 2017 Sep;39(9):1761-1769. doi: 10.1002/hed.24832. Epub 2017 May 31.
There is no widely accepted intervention in the prevention of acute mucositis during chemoradiotherapy for head and neck carcinoma. In the present double-blind study, we tested 4 natural agents, propolis, aloe vera, calendula, and chamomile versus placebo.
Patients undergoing concomitant chemo-intensity-modulated radiotherapy (IMRT) were given natural agent or matched placebo; grade 3 mucositis on physical examination according to Common Terminology Criteria for Adverse Events (CTCAE) version 3.0 was the primary endpoint. Various covariates were tested at logistic regression, including the individual amount of mucosa receiving at least 9.5 Gy per week (V9.5w).
One hundred seven patients were randomized from January 2011 to July 2014, and 104 were assessable (51%-49% were assigned to the placebo group and 53%-51% were assigned to the natural agent). Overall, 61 patients developed peak grade 3 mucositis with no difference between arms (P = .65). Conversely, V9.5w (P = .007) and primary site (P = .037) were independent predictors.
The selected natural agents do not prevent mucositis, whereas the role of V9.5w is confirmed.
在头颈部癌放化疗期间预防急性粘膜炎方面,尚无广泛接受的干预措施。在本双盲研究中,我们测试了4种天然制剂,即蜂胶、芦荟、金盏花和洋甘菊,并与安慰剂进行对比。
接受同步化疗调强放疗(IMRT)的患者被给予天然制剂或匹配的安慰剂;根据不良事件通用术语标准(CTCAE)第3.0版进行体格检查时出现3级粘膜炎为主要终点。在逻辑回归中测试了各种协变量,包括每周接受至少9.5 Gy照射的黏膜个体量(V9.5w)。
2011年1月至2014年7月,107例患者被随机分组,104例可进行评估(51% - 49%被分配到安慰剂组,53% - 51%被分配到天然制剂组)。总体而言,61例患者出现3级粘膜炎高峰,两组之间无差异(P = 0.65)。相反,V9.5w(P = 0.007)和原发部位(P = 0.037)是独立预测因素。
所选天然制剂不能预防粘膜炎,而V9.5w的作用得到证实。